Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
SSH's Cash to Debt is ranked higher than
85% of the 480 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SSH: No Debt )
SSH' s 10-Year Cash to Debt Range
Min: No Debt   Max: No Debt
Current: No Debt

Equity to Asset 0.93
SSH's Equity to Asset is ranked higher than
98% of the 450 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SSH: 0.93 )
SSH' s 10-Year Equity to Asset Range
Min: 0.93   Max: 0.95
Current: 0.93

0.93
0.95
Interest Coverage No Debt
SSH's Interest Coverage is ranked higher than
75% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 234.31 vs. SSH: No Debt )
SSH' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 3
Z-Score: 12.33
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -22140.68
SSH's Operating margin (%) is ranked lower than
57% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 5.50 vs. SSH: -22140.68 )
SSH' s 10-Year Operating margin (%) Range
Min: -38764.41   Max: -358.24
Current: -22140.68

-38764.41
-358.24
Net-margin (%) -21989.83
SSH's Net-margin (%) is ranked lower than
57% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 4.35 vs. SSH: -21989.83 )
SSH' s 10-Year Net-margin (%) Range
Min: -36877.97   Max: -358.24
Current: -21989.83

-36877.97
-358.24
ROE (%) -56.07
SSH's ROE (%) is ranked higher than
53% of the 449 Companies
in the Global Medical Devices industry.

( Industry Median: 5.02 vs. SSH: -56.07 )
SSH' s 10-Year ROE (%) Range
Min: -238.68   Max: -67.28
Current: -56.07

-238.68
-67.28
ROA (%) -52.72
SSH's ROA (%) is ranked higher than
53% of the 481 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. SSH: -52.72 )
SSH' s 10-Year ROA (%) Range
Min: -216.94   Max: -61.93
Current: -52.72

-216.94
-61.93
ROC (Joel Greenblatt) (%) -4739.84
SSH's ROC (Joel Greenblatt) (%) is ranked lower than
55% of the 480 Companies
in the Global Medical Devices industry.

( Industry Median: 6.67 vs. SSH: -4739.84 )
SSH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -4851.22   Max: -774.91
Current: -4739.84

-4851.22
-774.91
EBITDA Growth (3Y)(%) 462.50
SSH's EBITDA Growth (3Y)(%) is ranked higher than
100% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.80 vs. SSH: 462.50 )
SSH' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 462.5
Current: 462.5

0
462.5
EPS Growth (3Y)(%) 455.00
SSH's EPS Growth (3Y)(%) is ranked higher than
100% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. SSH: 455.00 )
SSH' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 455
Current: 455

0
455
» SSH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

SSH Guru Trades in

SSH Guru Trades in

Q3 2013

SSH Guru Trades in Q3 2013

Jim Simons 17,000 sh (New)
» More
Q4 2013

SSH Guru Trades in Q4 2013

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SSH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.70
SSH's P/B is ranked higher than
80% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 4.16 vs. SSH: 2.70 )
SSH' s 10-Year P/B Range
Min: 0   Max: 11.6
Current: 2.7

0
11.6
EV-to-EBIT -1.73
SSH's EV-to-EBIT is ranked higher than
64% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 68.02 vs. SSH: -1.73 )
SSH' s 10-Year EV-to-EBIT Range
Min: -3.6   Max: -2.5
Current: -1.73

-3.6
-2.5
Current Ratio 13.63
SSH's Current Ratio is ranked higher than
98% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 2.58 vs. SSH: 13.63 )
SSH' s 10-Year Current Ratio Range
Min: 1.06   Max: 63.13
Current: 13.63

1.06
63.13
Quick Ratio 13.63
SSH's Quick Ratio is ranked higher than
98% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. SSH: 13.63 )
SSH' s 10-Year Quick Ratio Range
Min: 1.06   Max: 63.13
Current: 13.63

1.06
63.13
Days Sales Outstanding 182.50
SSH's Days Sales Outstanding is ranked higher than
58% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 78.80 vs. SSH: 182.50 )
SSH' s 10-Year Days Sales Outstanding Range
Min: 6.99   Max: 803
Current: 182.5

6.99
803

Valuation & Return

vs
industry
vs
history
Price/Net Cash 2.79
SSH's Price/Net Cash is ranked higher than
98% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SSH: 2.79 )
SSH' s 10-Year Price/Net Cash Range
Min: 2.2   Max: 31.61
Current: 2.79

2.2
31.61
Price/Net Current Asset Value 2.79
SSH's Price/Net Current Asset Value is ranked higher than
97% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SSH: 2.79 )
SSH' s 10-Year Price/Net Current Asset Value Range
Min: 2.2   Max: 31.61
Current: 2.79

2.2
31.61
Price/Tangible Book 2.70
SSH's Price/Tangible Book is ranked higher than
85% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 6.96 vs. SSH: 2.70 )
SSH' s 10-Year Price/Tangible Book Range
Min: 2.13   Max: 32.6
Current: 2.7

2.13
32.6
Earnings Yield (Greenblatt) -57.80
SSH's Earnings Yield (Greenblatt) is ranked lower than
54% of the 476 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. SSH: -57.80 )
SSH' s 10-Year Earnings Yield (Greenblatt) Range
Min: -1413.4   Max: 0
Current: -57.8

-1413.4
0

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:SHC.Australia, 22S.Germany,
Sunshine Heart, Inc. was incorporated in Delaware on August 22, 2002. The company is an early-stage medical device company engaged in developing, manufacturing and commercializing its C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. Its C-Pulse Heart Assist System utilizes the scientific principles of intra-aortic balloon counter-pulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. It is in the process of obtaining regulatory approvals necessary to sell its product. Combined, these potential benefits may help reverse the heart failure process or maintain the patient's current condition, thereby potentially preventing the need for later-stage heart failure devices, such as LVADs, artificial hearts or transplants. Its competitors include: AbioMed, Inc., Berlin Heart GmbH, CardioKinetix, Inc., CircuLite, Inc. & HeartWare International Inc. Its business is subject to extensive federal and state government regulation.
» More Articles for SSH

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Sunshine Heart Receives FDA Approval for Interim Analysis of U.S. Pivotal Trial of C-Pulse(R) Heart... Feb 25 2015
Sunshine Heart to Present at the Cowen and Company 35th Annual Health Care Conference on March 4,... Feb 24 2015
SUNSHINE HEART, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Feb 19 2015
Sunshine Heart, Inc. Secures Up to $10 Million in Growth Capital From Silicon Valley Bank Feb 19 2015
Sunshine Heart Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Feb 12 2015
Is C-Pulse to Heart Failure What CAR-T is to Cancer? Near-Term Catalysts Could Lift Shares of this... Feb 05 2015
SUNSHINE HEART, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 12 2015
Sunshine Heart Provides Corporate Update Jan 12 2015
Sunshine Heart's German Erlangen Site Achieves First Implant for OPTIONS HF EU Post-Market Study Jan 08 2015
SUNSHINE HEART, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jan 07 2015
Sunshine Heart Appoints Claudia Drayton as Chief Financial Officer Jan 05 2015
SUNSHINE HEART, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 03 2014
SUNSHINE HEART, INC. Files SEC form 10-Q, Quarterly Report Oct 31 2014
Sunshine Heart (SSH) Worth Watching: Stock Gains 8.4% Sep 17 2014
SUNSHINE HEART, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Sep 16 2014
SUNSHINE HEART, INC. Files SEC form 8-K, Change in Directors or Principal Officers Sep 03 2014
SUNSHINE HEART, INC. Financials Aug 19 2014
Sunshine Heart (SSH) in Focus: Stock Moves 7.9% Higher Aug 14 2014
SUNSHINE HEART, INC. Files SEC form 10-Q, Quarterly Report Aug 12 2014
Micro Cap Sunshine Heart Faces Medical Device Industry Challenges, Hires Boston Scientific And... Jun 30 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK